Dr. Frederick W. Alt is the director of the Program in Cellular and Molecular Medicine at Boston Children’s Hospital, a professor of Genetics at Harvard Medical School, and an investigator of the Howard Hughes Medical Institute.
Dr. Alt, who was first funded by the Cancer Research Institute as a postdoctoral fellow, has made fundamental contributions to our understanding of B cell development and function, and the mechanisms underlying B cell lymphomas.
His honors include election to the National Academy of Sciences, and awards including the 2009 William B. Coley Award for Distinguished Research in Basic Immunology and the 2015 Szent-Györgyi Prize for Progress in Cancer Research. In recognition of his accomplishments, CRI also started the Frederick W. Alt Award, which honors a former CRI postdoctoral fellow who has achieved outstanding success that has impacted immunology. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Alt serves on the Postdoctoral Fellowship Review Committee.
Cancer is a complex and terrible disease, but with each new discovery we are making it less mysterious, more understandable, and ultimately less deadly. We are making progress.
¡Hagamos correr la voz sobre la inmunoterapia! Haga clic para compartir esta página con su comunidad.